Report: Cancer Fonden (Sweden): Difference between revisions
(Created page with "{{#subobject:Cancer Fonden |dct:title=Cancer Fonden |datatype=policymaking }} '''Sponsor, manager or home institution:''' Cancer Fonden. '''Primary purpose:''' To collaborate with healthcare organizations to map and evaluate methods for increasing participation in cancer screening programs. '''Type of information:''' Participation in the national screening programs; New cases of cervical, breast and colon cancer; Participation cancer screenings; Municipalities with...") |
m (Update categories.) |
||
| (11 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | |||
<span style="display:none">swedencountry</span> | |||
Go back to [[Sweden]] page | |||
'''Sponsor, manager or home institution:''' Cancer Fonden. | '''Primary purpose:''' To collaborate with healthcare organizations to map and evaluate methods for increasing participation in cancer screening programs. | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Cancer Fonden]]. | |||
'''Type of information:''' Participation in the national [[availableVariable::screening]]; New cases of cervical, breast and colon cancer; Participation cancer screenings; [[availableVariable::region|Municipalities]] with the highest and lowest participation in cancer screenings; [[availableVariable::cancer incidence]], [[availableVariable::income]] differences and participation in cancer screenings. [https://static-files.cancerfonden.se/CFrapport-vard-2021.pdf Click here to learn more]. | |||
''' | '''Data level:''' [[dataLevel::regional level]] and [[dataLevel::national level]]. | ||
''' | '''Cancer areas of interest:''' [[hasCancerType::C50: Breast cancer]], [[hasCancerType::C51-C58: Female genitalia cancer]], and [[hasCancerType::C15-C26: Digestive system cancers]]. [https://static-files.cancerfonden.se/CFrapport-vard-2021.pdf Click here to learn more]. | ||
''' | '''Access to information:''' [https://static-files.cancerfonden.se/CFrapport-vard-2021.pdf Click here to access]. | ||
<span style="display:none">Lobular</span> | |||
<span style="display:none">Breast</span> | |||
<span style="display:none">Nipple</span> | |||
<span style="display:none">Areola</span> | |||
<span style="display:none">Ductal</span> | |||
<span style="display:none">Vulva</span> | |||
<span style="display:none">Vagina</span> | |||
<span style="display:none">Cervix</span> | |||
<span style="display:none">Uterus</span> | |||
<span style="display:none">Ovary</span> | |||
<span style="display:none">Fallopian tubes</span> | |||
<span style="display:none">Endometrium</span> | |||
<span style="display:none">Esophagus</span> | |||
<span style="display:none">Stomach</span> | |||
<span style="display:none">Small intestine</span> | |||
<span style="display:none">Large intestine</span> | |||
<span style="display:none">Rectum</span> | |||
<span style="display:none">Anus</span> | |||
<span style="display:none">Liver</span> | |||
<span style="display:none">Gallbladder</span> | |||
<span style="display:none">Bile ducts</span> | |||
<span style="display:none">Pancreas</span> | |||
<span style="display:none">Colon</span> | |||
<span style="display:none">dataOwner::Cancer Fonden</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::region|Municipalities</span> | |||
<span style="display:none">availableVariable::cancer incidence</span> | |||
<span style="display:none">availableVariable::income</span> | |||
<span style="display:none">dataLevel::regional level</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
<span style="display:none">isReport</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
Latest revision as of 12:09, 14 December 2025
Go back to Sweden page
Primary purpose: To collaborate with healthcare organizations to map and evaluate methods for increasing participation in cancer screening programs.
Sponsor, manager or home institution: Cancer Fonden.
Type of information: Participation in the national screening; New cases of cervical, breast and colon cancer; Participation cancer screenings; Municipalities with the highest and lowest participation in cancer screenings; cancer incidence, income differences and participation in cancer screenings. Click here to learn more.
Data level: regional level and national level.
Cancer areas of interest: C50: Breast cancer, C51-C58: Female genitalia cancer, and C15-C26: Digestive system cancers. Click here to learn more.
Access to information: Click here to access.